Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Atopic DermatitisAtopicDermatitis+5 more
Estimated
~$10 – $8,750
Apollo Therapeutics LtdNCT07599813
Phase 2
A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08049820 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as ecze…
Atopic DermatitisEczema, Atopic
Estimated
~$10 – $7,500
PfizerNCT07216027
Phase 2
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)
The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pi…
Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more
Estimated
~$10 – $8,750
Corvus Pharmaceuticals, Inc.NCT07441395